POPS! Diabetes Care received U.S. Food and Drug Administration (FDA) clearance of their POPS!® one Blood Glucose Monitoring System yesterday.
Diabeloop announced this month it has received the CE marking for its “artificial pancreas system,” dubbed the DBLG1,™ for adults
Tandem Diabetes Care®, Inc., a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring
Xeris Pharmaceuticals Inc., submitted an NDA to the U.S. Food and Drug Administration yesterday for its Glucagon Rescue Pen, the company’s lead
Companion Medical has received FDA regulatory clearance for the Android version of its InPen(TM) app. The clearance paves the way for the release of
Medtronic’s MiniMed™ 670G hybrid closed-loop system, also known as ‘the world’s first artificial pancreas,’ has won
Get a little dLife delivered to your inbox every week.